Abnormal liver function associated with occupational exposure to dimethylformamide and hepatitis B virus

Journal of Occupational and Environmental Medicine

Volumn 43, Issue 5, 2001, Pages 474-482

  Luo, Jiin Chyuan John ^a,c   Kuo, Hsien Wen ^d   Cheng, Tsun Jen ^b   Chang, Ming J W ^d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; EPICHLOROHYDRIN; N,N DIMETHYLFORMAMIDE; TOLUENE;

ADULT; ARTICLE; BODY MASS; DOSE RESPONSE; DRINKING BEHAVIOR; EMPLOYMENT; FEMALE; HEPATITIS; HEPATITIS B VIRUS; HUMAN; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; RISK; TAIWAN; VIRUS CARRIER;

ANIMALIA; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 0035025899     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-200105000-00008     Document Type: Article

References (29)

1. Finkel AJ. Hamilton and Hardy's Industrial Toxicology. 4th ed. Boston: John Wright: 1983.
2. Massmann W. Toxicological investigations on dimethylformamide. Br J Ind Med. 1956;13:51-54.
3. Tanaka KI. Toxicity of dimethylformamide (DMF) to the young female rat. Int Arch Arbeitsmed. 1971;28:98-105.
4. Potter HP. Dimthylformamide-induced abdominal pain and liver injury. Arch Environ Health. 1973;27:340-341.
5. Redlich CA, Beckett WS, Sparer J. Liver disease associated with occupational exposure to the dimethylformamide. Ann Intern Med. 1988;108:680-686.
6. Wang J-D, Lai M-Y, Chang W-S. Dimethylformamide-induced liver damage among synthetic leather workers. Arch Environ Health. 1991;46:161-166.
7. Cai S-X, Huang M-Y, Ikeda M. Occupational dimethyl-formamide exposure. 3. Health effects of dimethylformamide after occupational exposure at low concentrations. Int Arch Occup Environ Health. 1992;63:461-468.
8. Wrbitzky R. Liver function in workers exposed to N, N-dimethylformamide during the production of synthetic textiles. Int Arch Occup Environ Health. 1999;72: 19-25.
9. Redlich CA, West AB, Fleming L, True LD, Riely CA. Clinical and pathological characteristics of hepatotoxicity associated with occupational exposure to dimethylformamide. Gastroenterology. 1990;99:748-757.
10. US Department of Health, Education and Welfare. Criteria for a Recommended Standard, Occupational Exposure to Epichlorohydrin. Washington. DC: US Government Printing Office; 1976:1-152. DHEW (NIOSH) Publication No. 76-206.
11. National Institute for Occupational Safety and Health. Criteria for a Recommended Standard, Occupational Exposure to Toluene. Washington, DC: US Government Printing Office: 1973:14-45. DHEW (NIOSH) Publication No (HSM) 7311023.
12. Chen CJ, Liang KY, Chang AS, Chang YC. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology. 1991;13:398-406.
13. Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res. 1991;51:5621-5625.
14. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic consideration. Hepatology. 1982;2(suppl):21s-26s.
15. Kuo HW, Huang YS, Lo JC, Cheng TJ, Wu MJC. Exposure to solvents in a synthetic leather manufacturing plant. Int Arch Occup Health. 2000;73:275-280.
16. SAS Institute. SAS Statistical Package, Version 6. Cary. NC: SAS; 1990.
17. Database III Plus. Torrance, CA: Ashton-Tate; 1986.
18. Redlich CA, Beckett WS, Riely CA, Barwick KM, Cullen MR. Dimethylformamide induced hepatotoxicity in factory workers. Hepatology (Baltimore). 1987; 7:1088.
19. Redlich CA, Beckkett WS, Cullen MR. Hepatitis associated with occupational exposure to the solvent dimethylformamide [abstract]. Clin Res. 1987;35:756.
20. Kawai T, Yasugi T, Mizunuma K, et al. Occupational dimethyl-formamide exposure. 2. Monomethylformamide excretion in urine after occupational dimethylformamide exposure. Int Arch Occup Environ Health. 1992;63:455-460.
21. Reichling JJ, Kaplan MM. Clinical use of serum enzymes in liver diseases. Dig Dis Sci. 1988;33:1601-1604.
22. Salvaggio A, Periti M, Miano L, Tavanelli M, Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem. 1991;37:720-723.
23. Burns CJ, Boswell JW, Olsen GW. Liver enzyme activity and body mass index. J Occup Environ Med. 1996;38:1248-1252.
24. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 1989;59: 1145-1156.
25. Powell EE, Cooksley WGE, Hanson R. The natural history of non-alcoholic steato-hepatitis: a follow up study of 22 patients for up to 21 years. Hepatology. 1990;11:74-79.
26. Kawai N, Kawai T, Kawai K. Ultrasonic and laboratory studies on fatty liver in white-collar workers. Jpn J Gastroenterol. 1995;92:1058-1065.
27. Ikai E, Ishizaki M, Suzuki Y, Ishida M, Noborizaka Y, Yamada Y. Association between hepatic steatosis, insulin resistance and hyperinsulinemia as related to hypertension in alcohol consumers and obese people. J Hum Hyperten. 1995;9: 101-105.
28. Yang PM, Huang GT, Lin JT, et al. Ultrasonography in the diagnosis of benign diffuse parenchyma liver disease: a prospective study. J Formos Med Assoc. 1988;187:966-976.
29. Khan KN, Yamasaki M, Yamasaki K, et al. Proposed abdominal sonographic staging to predict severity of liver diseases - analysis with peritoneoscopy and histology. Dig Dis Sci. 2000;45:554-564.